Genome-wide CNV analysis was performed on 2319 individuals with pathogenic BRCA1 pathogenic variants, including 1202 breast cancer cases (1117 non-breast cancer affected) and 357 ovarian cancer cases (1962 non-ovarian cancer affected), using published genotype data from Illumina 610K SNP arrays.14 A total of 60 893 CNVs were called across the study participants using four different algorithms (PennCNV, QuantiSNP, GNOSIS and CNVPartition) that passed the data quality threshold (see Methods and Materials). This evidence concerns the gene BRCA1 and breast carcinoma.